Skip to Main Content

Author Details

Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
2001
59
23
PMIDPaper TitleJournal TitlePublished Year
36343786UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.Cancer Lett2023
34412858Ductal-type mesonephric duct/remnant hyperplasia: distinguished from lobular or diffuse mesonephric hyperplasia by the presence of a myoepithelial cell layer and micropapillary tufting.Pathology2022
35456911MFG-E8 Reduces Aortic Intimal Proliferation in a Murine Model of Transplant Vasculopathy.Int J Mol Sci2022
36179244Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma.J Clin Endocrinol Metab2022
32948433Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.Urol Oncol2021
37435185Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding.Endocr Oncol2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
32589068The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.Arch Pathol Lab Med2021
31348743Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada.Can Urol Assoc J2020
32088909Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.Endocrine2020
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
32257499Mesenteric Lymph Node Recurrence of a Primary Colorectal Leiomyosarcoma.Case Rep Surg2020
32341866Wide-field optical spectroscopy system integrating reflectance and spatial frequency domain imaging to measure attenuation-corrected intrinsic tissue fluorescence in radical prostatectomy specimens.Biomed Opt Express2020
29623528A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.Pathol Oncol Res2019
31723584The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients.Transplant Direct2019
30113732Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.BJU Int2019
30136199The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.World J Urol2019
31265453Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.PLoS Med2019
31551924Isolated Pheochromocytoma in a 73-Year-Old Man With No Clinical Manifestations of Type 1 Neurofibromatosis Carrying an Unsuspected Deletion of the Entire <i>NF1</i> Gene.Front Endocrinol (Lausanne)2019
31572300Coexistence of Myelolipoma and Primary Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome.Front Endocrinol (Lausanne)2019
31452834V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss.Oncotarget2019
31018850Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.Radiat Oncol2019
29603326The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.Prostate2018
30200929The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.BMC Urol2018
29726953Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism.J Clin Endocrinol Metab2018
29542855Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics.BJU Int2018
27725152Biopsy Based Proteomic Assay Predicts Risk of Biochemical Recurrence after Radical Prostatectomy.J Urol2017
27043680Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.Medicine (Baltimore)2016
27260955Milk fat globule epidermal growth factor-8 limits tissue damage through inflammasome modulation during renal injury.J Leukoc Biol2016
25733599Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.Clin Cancer Res2015
26279712Prevalence and risk factors of contralateral extraprostatic extension in men undergoing radical prostatectomy for unilateral disease at biopsy: A global multi-institutional experience.Can Urol Assoc J2015
25737770Predictors of early continence following robot-assisted radical prostatectomy.Can Urol Assoc J2015
24411587A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma.Crit Rev Oncol Hematol2014
25024790Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experience.Can Urol Assoc J2014
24919183The morphologic and immunohistochemical spectrum of papillary renal cell carcinoma: study including 132 cases with pure type 1 and type 2 morphology as well as tumors with overlapping features.Am J Surg Pathol2014
24940455Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer.Can Urol Assoc J2014
24534079Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β.Mult Scler2014
24705317Endometrial stromal sarcoma involving the urinary bladder: a study of 6 cases.Am J Surg Pathol2014
24194978Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.Biopreserv Biobank2013
22253229p53 inhibits angiogenesis by inducing the production of Arresten.Cancer Res2012
22511415Effect of needle size on cancer detection, pain, bleeding and infection in TRUS-guided prostate biopsies: A prospective trial.Can Urol Assoc J2012
22532915Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment.Rare Tumors2012
20839061A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.Ann Surg Oncol2011
21782822Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation.J Immunol Methods2011
21271611IκB-Kinase-ε (IKKε/IKKi/IκBKε) expression and localization in prostate cancer tissues.Prostate2011
21167526Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.J Urol2011
20018438Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study.Eur Urol2010
21168633Evaluation of a preemptive strategy for BK polyomavirus-associated nephropathy based on prospective monitoring of BK viremia: a kidney transplantation center experience.Transplant Proc2010
20427489Clinical and biochemical features of seven adult adrenal ganglioneuromas.J Clin Endocrinol Metab2010
20410812Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.Am J Surg Pathol2010
  • 1 - 50 of 59

Recommended Authors

Anthony Sisk
University of California los angeles
Career Start Year 2017
Number of shared co-authors 3
Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 2
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 2
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 9
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 4
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 3
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 11
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 2
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 9
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 13
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 9
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 15
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 21
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 19
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 13
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 7
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 23
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 1
David Clouston
Career Start Year 1995
Number of shared co-authors 11
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 9
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 21
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 12
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 8
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 11
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 3
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 13
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 16
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 16
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 14
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1975
Number of shared co-authors 19

Collaborators

Fred Saad
University of Montreal Health Center
Co-authored papers 22
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 11
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 9
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Co-authored papers 8
Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers 8
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 7
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers 7
Simone Chevalier
McGill University Health Centre, McGill University
Co-authored papers 6
Andr??e-Anne Grosset
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers 6
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 5
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 5
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 5
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 5
Martin E Gleave
University of British Columbia
Co-authored papers 4
Nazim Benzerdjeb
Institut de Pathologie Multisite
Co-authored papers 4
Frederic Leblond
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 4
Mirela Birlea
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 4
Neil E Fleshner
University of Toronto
Co-authored papers 4
Kelly Aubertin
INSERM UMR_S9 and Universite de Strasbourg, Institut d'immunologie et d'hematologie
Co-authored papers 3
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 3
Eleonora Scarlata
Research Institute of the McGill University Health Center (RI-MUHC)
Co-authored papers 3
Ladan Fazli
University of British Columbia
Co-authored papers 3
Robert G Bristow
University of Toronto
Co-authored papers 3
Peter A Humphrey
Yale University School of Medicine
Co-authored papers 3
Andr?? Kougioumoutzakis
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 3
Herv?? Brisson
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 3
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Adeboye O Osunkoya
Emory University School of Medicine
Co-authored papers 2
Marie-Jos??e H??bert
Universite de Montreal
Co-authored papers 2
Release 1.2